…ntric Castleman disease was done, and interleukin 6 antagonist, siltuximab, was given every 4 weeks. Subsequently, the patient developed h…
4articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: siltuximab ×
siltuximab
This drug is selected. Its supporting articles are shown below.
Articles mentioning siltuximab
4 articles · page 1 of 1siltuximabhydroxychloroquineazathioprinemethylprednisoloneCastleman diseasesystemic lupus erythematosus
siltuximabBurkitt lymphomaB-cell acute lymphoblastic leukemiaB-ALLCAYAICANS
…ome. Following a protocol amendment to evaluate the efficacy of siltuximab as a first-line treatment of CRS, one patient received siltuxim…
siltuximabiMCDIgG4-related diseaseidiopathic multicentric Castleman diseaseIgG4-RD
… plasma cells. In addition, the patient showed improvement with siltuximab, an interleukin-6 inhibitor drug specific for iMCD. This challe…
axi-celAxicabtagene ciloleucelsiltuximabdexamethasonemethylprednisoloneanakinratocilizumabDiffuse large B-cell lymphoma (DLBCL)DLBCLnon-Hodgkin lymphomas
…mplications.Conclusion and Relevance In this real-world cohort, axi-cel showed predictable but significant toxicity, including universa…